{
  "id": 4994,
  "text": "宫颈注射显影剂后，前哨淋巴结通常在髂外血管内侧、髂内血管的子宫侧或闭孔窝的表面显影（图2）。前哨淋巴结通常由病理科医生进行超分期，以提高微转移的检出率，进而改变术后处理。4，a.按疾病分期提供的推荐方法是基于修订后的FIGO 2018分期（Bhatla N, Berek JS, F noma ofthe cervix uteri.Int J Gynecol Obstet 2019;145:129-135，勘误为“Revised FIGO Staging for carcinoma of the cervix uteri” [Int JGynecol Obstet 2019;145:129-135] Int J Gynecol Obstet 2019;147:279-280）。",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: 宫颈注射显影剂后，前哨淋巴结通常在髂外血管内侧、髂内血管的子宫侧或闭孔窝的表面显影（图2）。前哨淋巴结通常由病理科医生进行超分期，以提高微转移的检出率，进而改变术后处理。4，a.按疾病分期提供的推荐方法是基于修订后的FIGO 2018分期（Bhatla N, Berek JS, F noma ofthe cervix uteri.Int J Gynecol Obstet 2019;145:129-135，勘误为“Revised FIGO Staging for carcinoma of the cervix uteri” [Int JGynecol Obstet 2019;145:129-135] Int J Gynecol Obstet 2019;147:279-280）。\n\n<question>: ",
  "ChatGPT_response_0": "宫颈注射显影剂后，前哨淋巴结通常在髂外血管内侧、髂内血管的子宫侧或闭孔窝的表面显影。这些位置是前哨淋巴结在注射显影剂后常见的发现位置。前哨淋巴结的显影可以通过超分期来进行评估，以提高对微转移的检测率，并且可以影响术后处理的决策。在临床实践中，根据修订后的FIGO 2018分期提供的推荐方法进行评估和处理是常见做法。",
  "query": "宫颈注射显影剂后，前哨淋巴结通常在哪些位置显影？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 宫颈注射显影剂后，前哨淋巴结通常在哪些位置显影？\n\n<reference text>: 宫颈注射显影剂后，前哨淋巴结通常在髂外血管内侧、髂内血管的子宫侧或闭孔窝的表面显影（图2）。前哨淋巴结通常由病理科医生进行超分期，以提高微转移的检出率，进而改变术后处理。4，a.按疾病分期提供的推荐方法是基于修订后的FIGO 2018分期（Bhatla N, Berek JS, F noma ofthe cervix uteri.Int J Gynecol Obstet 2019;145:129-135，勘误为“Revised FIGO Staging for carcinoma of the cervix uteri” [Int JGynecol Obstet 2019;145:129-135] Int J Gynecol Obstet 2019;147:279-280）。\n\n<reply>: ",
  "response": "宫颈注射显影剂后，前哨淋巴结通常在髂外血管内侧、髂内血管的子宫侧或闭孔窝的表面显影。这些位置是前哨淋巴结在注射显影剂后常见的发现位置。前哨淋巴结的显影可以通过超分期来进行评估，以提高对微转移的检测率，并且可以影响术后处理的决策。在临床实践中，根据修订后的FIGO 2018分期提供的推荐方法进行评估和处理是常见做法。"
}